We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
HHS is calling on drug manufacturers to ramp up production capability so that the U.S. can vaccinate its entire population within six months of a pandemic flu outbreak, according to a government report issued May 3.
HHS has awarded slightly more than $1 billion in federal grants to five pharmaceutical companies to hasten development and production of cell-based influenza vaccines.
HHS wants domestic drug manufacturers to ramp up production capability enough so that the U.S. can vaccinate its entire population within six months of a pandemic flu outbreak, according to a government report issued May 3.
Medicaid spending more than doubled while the use of generic drugs for conditions that cost Medicaid the most fell sharply from 1997 to 2002, according to a report by HHS’ Agency for Healthcare Research and Quality (AHRQ).
Medicaid spending more than doubled while the use of generic drugs for conditions that cost Medicaid the most fell sharply from 1997 to 2002, according to a report by HHS’ Agency for Healthcare Research and Quality (AHRQ).
A bipartisan group of influential senators has petitioned PhRMA President Billy Tauzin to request that drugmakers continue to offer patient prescription programs (PAPs) to Medicare recipients.
Despite the push to implement a personalized approach to developing new medicines, the FDA faces numerous obstacles to doing so, including privacy concerns, financial limits and regulatory roadblocks, HHS Secretary Mike Leavitt said.
The Centers for Medicare & Medicaid Services (CMS) is dragging its feet in providing the necessary oversight to ensure laboratory genetic tests are valid, performed correctly and explained properly to patients, according to an advocacy group that says the tests are needed to realize the potential of personalized medicine.
A strain of virtually untreatable tuberculosis (TB) has been identified, raising concern about a possible pandemic, the U.S. Centers for Disease Control and Prevention (CDC) said March 23.
HHS has bought six million additional doses of antiviral medication to be used in case of a pandemic flu outbreak, bringing to 26 million the total number of courses purchased.